Authors:
Cwynarski, K
Goulding, R
Pocock, C
Dazzi, F
Craddock, C
Kaeda, J
Olavarria, E
Kanfer, E
Apperley, J
Lawler, M
Goldman, JM
Citation: K. Cwynarski et al., Immune haemolytic anaemia following T cell-depleted allogeneic bone marrowtransplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions, BONE MAR TR, 28(6), 2001, pp. 581-586
Authors:
Mc Gee, MM
Campiani, G
Ramunno, A
Fattorusso, C
Nacci, V
Lawler, M
Williams, DC
Zisterer, DM
Citation: Mm. Mc Gee et al., Pyrrolo-1,5-benzoxazepines induce apoptosis in chronic myelogenous leukemia (CML) cells by bypassing the apoptotic suppressor Bcr-Abl, J PHARM EXP, 296(1), 2001, pp. 31-40
Authors:
Schmidt-Supprian, M
Murphy, C
White, B
Lawler, M
Kapurniotu, A
Voelter, W
Smith, O
Bernhagen, J
Citation: M. Schmidt-supprian et al., Activated protein C inhibits tumor necrosis factor and macrophage migration inhibitory factor production in monocytes, EUR CYTOKIN, 11(3), 2000, pp. 407-413
Authors:
Keenan, C
Livingstone, WJ
White, B
Mynett-Johnson, L
Cusack, S
Lawler, M
Smith, OP
Citation: C. Keenan et al., Prevalence of the prothrombin G20210A mutation in the Irish populations: use of a novel polymerase chain reaction approach, BL COAG FIB, 11(7), 2000, pp. 669-672
Authors:
Ang, YS
Mahmud, N
White, B
Byrne, M
Kelly, A
Lawler, M
McDonald, GSA
Smith, OP
Keeling, PWN
Citation: Ys. Ang et al., Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease, ALIM PHARM, 14(8), 2000, pp. 1015-1022
Authors:
Craddock, C
Bardy, P
Kreiter, S
Johnston, R
Apperley, J
Marks, D
Huber, C
Kolbe, K
Goulding, R
Lawler, M
Goldman, J
Hughes, T
Derigs, G
Citation: C. Craddock et al., Engraftment of T-cell-depleted allogeneic haematopoietic stem cells using a reduced intensity conditioning regimen, BR J HAEM, 111(3), 2000, pp. 797-800
Authors:
Livingstone, WJ
Keenan, C
White, B
Mynett-Johnson, L
Lawler, M
Mayne, P
Smith, OP
Citation: Wj. Livingstone et al., Prevalence of the factor VR506Q mutation in two Irish control populations:use of a novel nested polymerase chain reaction approach, BR J HAEM, 111(2), 2000, pp. 559-561
Authors:
White, B
Schmidt, M
Murphy, C
Livingstone, W
O'Toole, D
Lawler, M
O'Neill, L
Kelleher, D
Schwarz, HP
Smith, OP
Citation: B. White et al., Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappa B (NF-kappa B) and tumour necrosis factor alpha(TNF-alpha) production in the THP-1 monocytic cell line, BR J HAEM, 110(1), 2000, pp. 130-134
Authors:
Locatelli, F
Bruno, B
Zecca, M
Van-Lint, MT
McCann, S
Arcese, W
Dallorso, S
Di Bartolomeo, P
Fagioli, F
Locasciulli, A
Lawler, M
Bacigalupo, A
Citation: F. Locatelli et al., Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia givenallogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial, BLOOD, 96(5), 2000, pp. 1690-1697
Authors:
Duggan, C
Schmidt, M
Lawler, M
White, B
Cusack, S
McCann, SR
Smith, OP
Citation: C. Duggan et al., The prothrombin gene variant G20210A but not factor V Leiden may be associated with veno-occlusive disease following BMT, BONE MAR TR, 24(6), 1999, pp. 693-694
Authors:
Rozemuller, H
Terpstra, W
Rombouts, EJC
Lawler, M
Byrne, C
FitzGerald, DJP
Kreitman, RJ
Wielenga, JJ
Lowenberg, B
Touw, IP
Hagenbeek, A
Martens, ACM
Citation: H. Rozemuller et al., GM-CSF receptor targeted treatment of primary AML in SCID mice using Diphtheria toxin fused to huGM-CSF, LEUKEMIA, 12(12), 1998, pp. 1962-1970
Authors:
Deane, M
Koh, M
Foroni, L
Galactowicz, G
Hoffbrand, AV
Lawler, M
Secker-Walker, L
Prentice, HG
Citation: M. Deane et al., FLAG-idarubicin and allogeneic stem cell transplantation for Ph-positive ALL beyond first remission, BONE MAR TR, 22(12), 1998, pp. 1137-1143